New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareFOXO4-DRI vs Palmitoyl Dipeptide-6

FOXO4-DRI vs Palmitoyl Dipeptide-6

Side-by-side comparison of key properties, dosing, and research.

Anti-Aging & Longevity
FOXO4-DRI
Skin & CosmeticAnti-Aging & Longevity
Palmitoyl Dipeptide-6
Summary
FOXO4-DRI is a D-retro-inverso peptide derived from the FOXO4 protein that selectively induces apoptosis in senescent cells. By disrupting the FOXO4-p53 interaction that keeps senescent cells alive, it triggers programmed cell death specifically in these aging, pro-inflammatory cells while sparing healthy tissue.
Palmitoyl Dipeptide-6 is a synthetic dipeptide (lysine-threonine) with a palmitoyl fatty acid tail, designed to penetrate the skin barrier and stimulate the extracellular matrix components essential for skin firmness. It activates fibronectin and type IV collagen synthesis, improving skin density and firmness particularly in mature or sagging skin.
Half-Life
Estimated 2-4 hours (D-amino acid confers resistance to proteolysis)
Not applicable (topical)
Admin Route
Subcutaneous, Intraperitoneal (research)
Topical
Research
Typical Dose
5 mg/kg in rodent studies; human equivalent approximately 0.5-1 mg/kg
0.005–0.05% in formulation
Frequency
3 consecutive days per cycle
Once or twice daily
Key Benefits
  • Selectively clears senescent cells (senolytics)
  • Reduces senescence-associated secretory phenotype (SASP) and chronic inflammation
  • Demonstrated restoration of physical fitness in aged mice
  • May improve healthspan and reduce age-related tissue dysfunction
  • Potential for treatment of age-related pathologies driven by cellular senescence
  • Does not affect healthy non-senescent cells at therapeutic doses
  • Increases skin firmness and density
  • Stimulates fibronectin and collagen IV production
  • Strengthens the dermal-epidermal junction
  • Reduces skin sagging in mature skin
  • Improves skin texture and smoothness
  • Supports extracellular matrix integrity
Side Effects
  • Limited human data; largely preclinical evidence
  • Possible temporary inflammatory response as senescent cells are cleared (senolytic effect)
  • Weight loss observed at high doses in rodent studies
  • Unknown long-term safety profile in humans
  • Generally well-tolerated
  • Rare mild skin irritation in sensitive individuals
  • No known systemic effects at cosmetic concentrations
Stacks With